However, a drawback is that a pathway found significant based on mutational information might not be significant when evaluated with other omics, potentially leading to contradictions or paradoxes.
← all excerpts
StellarPath: Hierarchical-vertical multi-omics classifier synergizes stable markers and interpretable similarity networks for patient profiling.
1
—
—